Ligand validation:6HRO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6HRO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HRO_NAG_A_601	80%	85%	0.094	0.942	0.23	0.51	-	-	0	0	100%	0.9333
6HRO_NAG_A_602	53%	81%	0.109	0.868	0.31	0.51	-	-	0	0	100%	0.9333
6HRO_NAG_A_604	18%	83%	0.174	0.759	0.3	0.48	-	-	0	0	100%	0.9333
6HRO_NAG_B_701	3%	78%	0.166	0.485	0.43	0.46	-	-	0	0	100%	0.9333
6HRO_NAG_A_603	2%	50%	0.151	0.432	0.89	1.04	1	1	0	0	100%	0.9333
6F6S_NAG_B_701	79%	82%	0.128	0.974	0.29	0.5	-	-	0	0	100%	0.9333
7SSR_NAG_A_601	75%	78%	0.112	0.945	0.34	0.54	-	-	0	0	100%	0.9333
7LYD_NAG_A_601	75%	72%	0.124	0.957	0.28	0.77	-	1	0	0	100%	0.9333
6F6N_NAG_A_501	72%	86%	0.133	0.958	0.21	0.51	-	-	0	0	100%	0.9333
6G9B_NAG_A_601	70%	42%	0.112	0.93	1.29	0.97	1	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.